| pubmed-article:21317835 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21317835 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:21317835 | lifeskim:mentions | umls-concept:C0040864 | lld:lifeskim |
| pubmed-article:21317835 | lifeskim:mentions | umls-concept:C0242852 | lld:lifeskim |
| pubmed-article:21317835 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:21317835 | lifeskim:mentions | umls-concept:C2825951 | lld:lifeskim |
| pubmed-article:21317835 | lifeskim:mentions | umls-concept:C1517572 | lld:lifeskim |
| pubmed-article:21317835 | lifeskim:mentions | umls-concept:C1656863 | lld:lifeskim |
| pubmed-article:21317835 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:21317835 | pubmed:dateCreated | 2011-8-15 | lld:pubmed |
| pubmed-article:21317835 | pubmed:abstractText | To evaluate the midterm anatomical and functional outcomes of intravitreal injection of low-dose triamcinolone acetonide in silicone oil-filled eyes as an adjunctive treatment for proliferative vitreoretinopathy. | lld:pubmed |
| pubmed-article:21317835 | pubmed:language | eng | lld:pubmed |
| pubmed-article:21317835 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21317835 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:21317835 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21317835 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21317835 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21317835 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:21317835 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:21317835 | pubmed:issn | 1539-2864 | lld:pubmed |
| pubmed-article:21317835 | pubmed:author | pubmed-author:PhamJ NJN | lld:pubmed |
| pubmed-article:21317835 | pubmed:author | pubmed-author:LamDennis S... | lld:pubmed |
| pubmed-article:21317835 | pubmed:author | pubmed-author:ChenWeiqiW | lld:pubmed |
| pubmed-article:21317835 | pubmed:author | pubmed-author:FokAndrewA | lld:pubmed |
| pubmed-article:21317835 | pubmed:author | pubmed-author:ChenHaoyuH | lld:pubmed |
| pubmed-article:21317835 | pubmed:author | pubmed-author:HuYijunY | lld:pubmed |
| pubmed-article:21317835 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:21317835 | pubmed:volume | 31 | lld:pubmed |
| pubmed-article:21317835 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21317835 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21317835 | pubmed:pagination | 1137-42 | lld:pubmed |
| pubmed-article:21317835 | pubmed:meshHeading | pubmed-meshheading:21317835... | lld:pubmed |
| pubmed-article:21317835 | pubmed:meshHeading | pubmed-meshheading:21317835... | lld:pubmed |
| pubmed-article:21317835 | pubmed:meshHeading | pubmed-meshheading:21317835... | lld:pubmed |
| pubmed-article:21317835 | pubmed:meshHeading | pubmed-meshheading:21317835... | lld:pubmed |
| pubmed-article:21317835 | pubmed:meshHeading | pubmed-meshheading:21317835... | lld:pubmed |
| pubmed-article:21317835 | pubmed:meshHeading | pubmed-meshheading:21317835... | lld:pubmed |
| pubmed-article:21317835 | pubmed:meshHeading | pubmed-meshheading:21317835... | lld:pubmed |
| pubmed-article:21317835 | pubmed:meshHeading | pubmed-meshheading:21317835... | lld:pubmed |
| pubmed-article:21317835 | pubmed:meshHeading | pubmed-meshheading:21317835... | lld:pubmed |
| pubmed-article:21317835 | pubmed:meshHeading | pubmed-meshheading:21317835... | lld:pubmed |
| pubmed-article:21317835 | pubmed:meshHeading | pubmed-meshheading:21317835... | lld:pubmed |
| pubmed-article:21317835 | pubmed:meshHeading | pubmed-meshheading:21317835... | lld:pubmed |
| pubmed-article:21317835 | pubmed:meshHeading | pubmed-meshheading:21317835... | lld:pubmed |
| pubmed-article:21317835 | pubmed:meshHeading | pubmed-meshheading:21317835... | lld:pubmed |
| pubmed-article:21317835 | pubmed:meshHeading | pubmed-meshheading:21317835... | lld:pubmed |
| pubmed-article:21317835 | pubmed:meshHeading | pubmed-meshheading:21317835... | lld:pubmed |
| pubmed-article:21317835 | pubmed:meshHeading | pubmed-meshheading:21317835... | lld:pubmed |
| pubmed-article:21317835 | pubmed:meshHeading | pubmed-meshheading:21317835... | lld:pubmed |
| pubmed-article:21317835 | pubmed:meshHeading | pubmed-meshheading:21317835... | lld:pubmed |
| pubmed-article:21317835 | pubmed:meshHeading | pubmed-meshheading:21317835... | lld:pubmed |
| pubmed-article:21317835 | pubmed:meshHeading | pubmed-meshheading:21317835... | lld:pubmed |
| pubmed-article:21317835 | pubmed:meshHeading | pubmed-meshheading:21317835... | lld:pubmed |
| pubmed-article:21317835 | pubmed:year | 2011 | lld:pubmed |
| pubmed-article:21317835 | pubmed:articleTitle | Midterm results of low-dose intravitreal triamcinolone as adjunctive treatment for proliferative vitreoretinopathy. | lld:pubmed |
| pubmed-article:21317835 | pubmed:affiliation | Joint Shantou International Eye Center of the Shantou University & Chinese University of Hong Kong, Shantou, China. | lld:pubmed |
| pubmed-article:21317835 | pubmed:publicationType | Journal Article | lld:pubmed |
